Sven Petto

[¹⁶¹Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [¹⁷⁷Lu]Lu-PSMA-617

Andrea Schaefer-Schuler, Caroline Burgard, Arne Blickle et al. · Theranostics · 2024 · 42 citations · Full text

[89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates

Florian Rosar, Andrea Schaefer-Schuler, Mark Bartholomä et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 23 citations · Full text

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Florian Rosar, Fadi Khreish, Robert J. Marlowe et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 17 citations · Full text

Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT

Florian Rosar, Caroline Burgard, Scott David et al. · Scientific Reports · 2024 · 14 citations · Full text

Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry

Caroline Burgard, C. Hein, Arne Blickle et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 12 citations · Full text